Biologic Therapies Summit IX: Immune-based Inflammatory Diseases Through the Lens of COVID-19 and Specific Questions in Vasculitis Treatment
What dose and duration of glucocorticoids should be used in ANCA-associated vasculitis?
Release date: August 20, 2021
Expiration date: August 20, 2023
Estimated Time of Completion: 30 minutes
Description
In the Biologic Therapies Summit IX: Immune-based Inflammatory Diseases Through the Lens of COVID-19 and Specific Questions in Vasculitis Treatment online series, an international, multi-disciplinary faculty of experts focuses on immune-mediated disease, with a focus on new perspectives due to COVID-19. Additionally, there is a focus on vasculitis and factors that influence the selection of treatments for vasculitis disorders.
What dose and duration of glucocorticoids should be used in ANCA-associated vasculitis? webcast highlights issues related to the use of glucocorticoids in the treatment of ANCA-associated vasculitis.
Disclosures
In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
Leonard H. Calabrese, DO | Abbvie Pharmaceuticals, BMS, Genentech/Roche, Janssen, Novartis | Consulting Teaching and Speaking |
Astra Zeneca, Crescendo | Teaching and Speaking | |
GSK, Regeneron, Sanofi Aventis, UCB | Consulting |
M. Elaine Husni, MD | Abbvie Pharmaceuticals, Amgen, Bristol-Myers Squibb Co., Janssen, Lilly, Regeneron | Consulting Membership on advisory committee or review panels |
Genenetch, UCB, Inc. | Consulting | |
Novartis Pharmaceuticals | Consulting Membership on advisory committee or review panels Teaching and Speaking |
|
Pfizer, Inc. | Membership on advisory committee or review panels | |
WebMD | Consulting Teaching and Speaking |
Carol Langford, MD | Abbvie Pharmaceuticals | Non-paid consultant for research |
Astrazeneca Pharmaceuticals, Bristol-Myers Squibb Co. | Non-paid consultant for research Clinical trial funding support |
|
Chemocentryx, Genenetch, GlaxoSmithKline | Clinical trial funding support |
Peter Merkel, MD | Abbvie Pharmaceuticals |
Consulting |
Bristol-Myers Squibb Co. |
Consulting |
|
Chemocentryx |
Consulting |
|
GSK |
Consulting |
|
Genentech/Roche |
Consulting |
|
Boehringer Ingelheim |
Consulting |
|
CSL Behring |
Consulting |
|
Forbius |
Consulting |
|
Genzyme/Sanofi |
Consulting |
|
Janssen |
Consulting |
|
InflaRx |
Consulting |
|
Kiniksa Pharmaceuticals |
Consulting |
|
Kyverna |
Consulting |
|
Magenta Therapeutics |
Consulting |
|
Novartis |
Consulting |
|
Pfizer |
Consulting |
|
Sparrow Pharmaceuticals |
Consulting |
|
Takeda |
Consulting |
|
Talaris Therapeutics |
Consulting |
|
Astra Zeneca |
Consulting |
|
Uptodate |
Royalties |
The following faculty have indicated she has no relationship which, in the context of her presentation(s), could be perceived as a potential conflict of interest:
Cassandra Calabrese, DO
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Internet Enduring activity from:
AbbVie, Inc.
Bristol-Myers Squibb Company
Genentech USA, Inc.
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
UCB, Inc.
The Cleveland Clinic Foundation Center for Continuing Education
acknowledges educational grants for partial support of the Live activity from:
AbbVie, Inc.
Bristol-Myers Squibb Company
Genentech USA, Inc.
Janssen Scientific Affairs, LLC
Lilly USA, LLC
Novartis Pharmaceuticals Corporation
Pfizer Inc.
UCB, Inc.
This CME activity was produced by the Cleveland Clinic Center for Continuing Education
and
Cleveland Clinic's RJ Fasenmyer Center for Clinical Immunology.